⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8987953 | 0.74 | — | — | |
| SCHEMBL775060 | 0.71 | — | — | |
| SCHEMBL7179079 | 0.67 | — | — | |
| SCHEMBL1818106 | 0.65 | — | — | |
| SCHEMBL7178269 | 0.65 | — | — | |
| SCHEMBL1820701 | 0.65 | — | — | |
| SCHEMBL1651237 | 0.65 | — | — | |
| SCHEMBL2562634 | 0.65 | — | — | |
| SCHEMBL752148 | 0.65 | — | — | |
| SCHEMBL380209 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3464324-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | Ferring B.V. (NL) | 2019-04-10 | — | — | EP | claimed |
| WO-2017207760-A1 | ANGIOTENSIN-1-RECEPTOR ANTAGONISTS | FERRING B.V. (NL) | 2017-12-07 | — | — | WO | claimed |
| EP-2968240-A2 | PHYSIOLOGICAL LIGANDS FOR GPR139 | Janssen Pharmaceutica, N.V. (BE) | 2016-01-20 | — | — | EP | claimed |
| WO-2014152917-A2 | PHYSIOLOGICAL LIGANDS FOR GPR139 | JANSSEN PHARMACEUTICA NV (BE) | 2014-09-25 | — | — | WO | claimed |
| WO-2014002109-A1 | SUBSTITUTED TETRAZOLE COMPOUNDS AND PROCESS THEREOF | RALLIS INDIA LIMITED (IN) | 2014-01-03 | — | — | WO | claimed |
| JP-2008537967-A | — | — | 2008-10-02 | — | — | JP | claimed |
| EP-1863875-A1 | SELF-ADHESIVE ADDITION CROSS LINKING SILICON-RUBBER BLENDS, METHOD FOR THE PRODUCTION THEREOF, METHOD FOR PRODUCING COMPOSITE MOULDED PARTS AND THE USE THEREOF | Momentive Performance Materials GmbH (DE) | 2007-12-12 | — | — | EP | claimed |
| EP-1815545-A2 | ALKALINE FLUORIDE DOPE MOLECULAR FILMS AND APPLICATIONS FOR P-N JUNCTION AND FIELD-EFFECT TRANSISTOR DEVICES | Lu, Zheng-Hong (CA) | 2007-08-08 | — | — | EP | claimed |
| WO-2006100098-A1 | SELF-ADHESIVE ADDITION CROSS LINKING SILICON-RUBBER BLENDS, METHOD FOR THE PRODUCTION THEREOF, METHOD FOR PRODUCING COMPOSITE MOULDED PARTS AND THE USE THEREOF | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2006-09-28 | — | — | WO | claimed |
| WO-2006045201-A2 | ALKALINE FLUORIDE DOPE MOLECULAR FILMS AND APPLICATIONS FOR P-N JUNCTION AND FIELD-EFFECT TRANSISTOR DEVICES | LU ZHENG-HONG (CA) | 2006-05-04 | — | — | WO | claimed |
| US-7012065-B2 | Cyclosporins for the treatment of immune disorders | ENANTA PHARMACEUTICALS, INC. (US) | 2006-03-14 | — | — | US | claimed |
| WO-2004072108-A1 | CYCLOSPORINS FOR THE TREATMENT OF IMMUNE DISORDERS | ENANTA PHARMACEUTICALS, INC. (US) | 2004-08-26 | — | — | WO | claimed |
| US-20040157768-A1 | Cyclosporins for the treatment of immune disorders | ENANTA PHARMACEUTICALS, INC. | 2004-08-12 | — | — | US | claimed |
| EP-0837124-B1 | Fluorescent whitening agent formulation | CIBA SC HOLDING AG (CH) | 2003-12-03 | — | — | EP | claimed |
| EP-0742281-B1 | Fluorescent-whitening agents containing formulations | CIBA SC HOLDING AG (CH) | 2003-04-16 | — | — | EP | claimed |
| EP-0837124-A2 | Fluorescent whitening agent formulation | Ciba SC Holding AG (CH) | 1998-04-22 | — | — | EP | claimed |
| US-5695687-A | Anhydrous fluorescent whitening agent formulation | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1997-12-09 | — | — | US | claimed |
| EP-0742281-A2 | Fluorescent-whitening agents containing formulations | CIBA-GEIGY AG (CH) | 1996-11-13 | — | — | EP | claimed |
| US-20240217905-A1 | CHROMIUM-CATALYZED PRODUCTION OF ALCOHOLS FROM HYDROCARBONS IN THE PRESENCE OF OXYGEN | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-07-04 | — | — | US | disclosed |
| EP-0186626-A2 | Titanocenes and compositions curable by irradiation containing these titanocenes | CIBA-GEIGY AG (CH) | 1986-07-02 | — | — | EP | disclosed |